Financial Architects (New Jersey)’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
CFGS
RJA
MCM
SPIA
Financial Architects (New Jersey)'s IHE Position: Q3 2020 in Review
Financial Architects (New Jersey) sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2020, closing a stake of 1,173 shares — an estimated $60K sold.
Financial Architects (New Jersey) first reported a position in IHE in Q1 2015 and held it in 21 quarters. The position peaked at $255K in Q3 2015. 94 funds tracked by Wall St. Rank hold IHE as of Q3 2020.
- Financial Architects (New Jersey) reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2020 after selling out during the quarter.
- Financial Architects (New Jersey) sold 1,173 iShares US Pharmaceuticals ETF shares in Q3 2020, an estimated $60K.
- Financial Architects (New Jersey) first reported a position in iShares US Pharmaceuticals ETF in Q1 2015 and held it in 21 quarters.
- Financial Architects (New Jersey)'s iShares US Pharmaceuticals ETF position peaked at $255K in Q3 2015.
- 94 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2020.
Based on Financial Architects (New Jersey)'s 13F filing for Q3 2020, filed 9 Nov 2020.